Clinical Trial Update: Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial [Phase 2]

View source ↗

Summary

A Phase 2 trial to evaluate zinc supplementation in sickle cell disease as a precursor to the Think Zinc for Bones Trial, currently recruiting at UCSF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Zinc supplement (zinc)

Snippet

Sponsor: University of California, San Francisco | Conditions: Sickle Cell Disease | Phase 2 | Status: RECRUITING